| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 316.38B | 315.42B | 299.60B | 275.06B | 253.39B | 283.75B |
| Gross Profit | 114.84B | 114.78B | 108.96B | 97.93B | 95.00B | 126.76B |
| EBITDA | 29.65B | 34.36B | 41.08B | 33.47B | 30.21B | 23.86B |
| Net Income | 10.74B | 12.49B | 17.58B | 13.67B | 13.96B | 8.75B |
Balance Sheet | ||||||
| Total Assets | 425.53B | 435.07B | 431.60B | 396.73B | 382.02B | 369.15B |
| Cash, Cash Equivalents and Short-Term Investments | 86.64B | 98.48B | 80.76B | 70.75B | 81.01B | 88.42B |
| Total Debt | 20.25B | 21.14B | 12.33B | 10.65B | 5.86B | 5.41B |
| Total Liabilities | 105.94B | 112.19B | 109.99B | 95.39B | 83.45B | 81.86B |
| Stockholders Equity | 290.10B | 292.82B | 292.21B | 272.29B | 268.97B | 258.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.41B | 12.90B | 4.32B | 2.37B | 12.19B |
| Operating Cash Flow | 0.00 | 26.57B | 25.57B | 19.48B | 16.14B | 23.18B |
| Investing Cash Flow | 0.00 | -12.28B | -2.30B | -21.47B | -10.40B | -8.56B |
| Financing Cash Flow | 0.00 | -9.06B | -7.38B | -12.74B | -10.07B | -6.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥300.83B | 23.75 | 4.19% | 1.66% | 0.74% | 5.88% | |
73 Outperform | ¥120.21B | 14.22 | ― | 1.08% | 0.48% | -4.27% | |
72 Outperform | ¥1.45T | 23.64 | 11.19% | 1.46% | 2.65% | -5.76% | |
71 Outperform | ¥622.46B | 20.30 | 9.28% | 1.30% | 5.50% | 27.32% | |
65 Neutral | ¥393.51B | 76.68 | 2.66% | 1.64% | 8.40% | -23.50% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥4.83T | 62.42 | 9.46% | 1.32% | 1.99% | -18.79% |